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Abstract
Background:  Recently, about 2.35% of  the world populations are estimated to be chronically infected with hepatitis C virus 
(HCV). Previous cohort studies indicated that obesity increases risk of  hepatic steatosis and fibrosis in non-diabetic patients with 
chronic hepatitis C infection due to diminished response to anti-viral therapy and as a result obesity is considered as an important 
factor in the progression of  chronic HCV. However, there is a strong association between BMI and the human immune system 
among HCV patients.
Objective: This study aimed to examine effects of  weight reduction program on selected immune parameters among HCV 
Saudi patients. 
Material and methods: One-hundred obese Saudi patients with chronic HCV infection participated in this study, their age 
ranged from 50- 58 years and their body mass index (BMI) ranged from 30-35 kg/m2. All Subjects were included in two groups: 
The first group received weight reduction program in the form of  treadmill aerobic exercises in addition to diet control whereas, 
the second group received no therapeutic intervention. Parameters of  CD3, CD4 and CD8 were quantified; Leukocyte, differ-
ential counts and BMI were measured before and after 3 months, at the end of  the study. 
Results: The mean values of  BMI, white blood cells, total neutrophil count, monocytes, CD3, CD4 and CD8 were significantly 
decreased in the training group as a result of  weight loss program; however the results of  the control group were not significant. 
Also, there were significant differences between both groups at the end of  the study.
Conclusion: Weight loss modulates immune system parameters of  patients with HCV.
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Introduction
Globally, an estimated 180 million people are chronically 
infected with HCV and 3 to 4 million are newly infected 
each year1,2.  Hepatitis C virus (HCV) infection is one of  
the main causes of  chronic liver disease worldwide3 and 
persistent infection occurs in 50 to 80% of  those infected 
and may lead to the development of  cirrhosis and subse-
quent hepatocellular carcinoma1.
 
The progression of  HCV involves changes in the cellular 
immunity of  those affected4,5. Some studies have indicat-
ed that the cellular immunity of  HCV patients undergoes 
alterations, leading to poor immunological responses or 
dysfunctions6-8.
 
Obesity has also been associated with decreased immu-
nocompetence as it alters innate and adaptive immunity 
and immunity deterioration is related to the grade of  obe-
sity9. Moreover, impaired immune responses have also 
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been suggested to occur in obese humans. Studies indi-
cated that the incidence and severity of  certain infections 
are higher in obese individuals when compared to lean 
people10,11.  Retrospective and prospective studies showed 
obesity to be an independent risk factor for infection af-
ter trauma12-14. In a prospective cohort study of  critically 
ill trauma patients, obese patients had more than two fold 
increased risk of  acquiring infection12. Also, Renehan et 
al. demonstrated an association of  obesity with 25–40% 
of  certain malignancies in both obese men and women15.
 
Many authors reported dysregulation and alteration in 
number of  immune cells in obese subjects. Obese sub-
jects showed either increased or decreased total lym-
phocytes in peripheral blood populations16-19 and had 
decreased CD8+ T cell population along with increased 
or decreased CD4+T cells18,19. Moreover, many previous 
studies as Moulin et al. who showed in their study that 
obesity is associated with the modulation of  immune 
parameters23, elevated numbers of  circulating immune 
cells as neutrophil, monocyte, leukocyte and total white 
blood cells (WBC)16,24, as well as elevated activation levels 
of  certain WBC and suppressed immune cell function17. 
Also, several authors have reported a chronic inflamma-
tion status in individuals with higher BMI25-27 which was 
associated with elevated amounts of  white blood cells, 
neutrophils, and monocytes in the blood of  all partici-
pants with BMI higher than that of  the control group28. 
Also,Kintscher et al. observed an increased number of  
CD3 and CD4 lymphocytes in the peripheral blood of  
obese women correlating with body mass index (BMI)29. 
Finally, Antuna-Puente  et al. found that BMI is positively 
correlated with the number of  macrophages in adipose 
tissue30.   
 
As there are limited studies reporting the benefits of  life-
style modification on immune system response among 
hepatitis C virus Saudi patients. This study aimed to ex-
amine effects of  a weight reduction program on selected 
immune parameters among HCV Saudi patients.
Patients and methods
Subjects
One hundred non-hypertensive, non-cirrhotic Saudi pa-
tients with chronic HCV infection;their age ranged from 
50 to 38 (41.63 ± 4.57) years, were selected  on referral 
to Gastroenterology and Hepatology Department, King 
Abdulaziz University Teaching Hospital, Saudi Arabia. 
All participants were anti HCV positive by enzyme-linked 
immunosorbent assay (ELISA). Exclusion criteria includ-
ed other potential causes of  liver disease, such as alcohol-
ism or autoimmune phenomena. Only patients diagnosed 
with chronic HCV mono-infection and had anti HCV an-
tibodies by ELISA were selected to undergo Real-Time 
polymerase chain reaction (RT-PCR) and were treat-
ed with combined pegylatedinterferon--alfa (PEG-IF-
Nα)-ribavirin therapy. All participants were free to with-
draw from the study at any time. Patients were divided in 
to two equal groups: Group (A):  received weight reduc-
tion program in the form of  treadmill aerobic exercises in 
addition to diet control, Whereas group (B): received no 
therapeutic intervention. The CONSORT diagram out-
lining the details of  the screening, run-in and random-
ization phases of  the study and reasons for participant 
exclusion illustrated in figure (1). Informed consent was 
obtained from all participants. This study was approved 
by the Scientific Research Ethical Committee, Faculty of  
Applied Medical Sciences at King Abdulaziz University. 
                                                                       
Measurements
Clinical and laboratory analysis were performed by inde-
pendent assessors who were blinded to group assignment 
and not involved in the routine treatment of  the patients, 
however the following measurements were taken before 
the study and after 3 months at the end of  the study:
A. Real-Time polymerase chain reaction (RT-PCR): 
Ten milliliter blood samples were collected from each 
participant at study entry. The blood samples were ob-
tained using disposable needles and heparinized vacuum 
syringes and stored at –70°C until assayed. Serum sam-
ples of  all participants were tested for Real-Time poly-
merase chain reaction (RT-PCR) to detect serum HCV 
RNA levels by polymerase chain reaction using the CO-
BAS TaqMan HCV test, v2.0 (Roche Diagnostics, India-
napolis, NJ, USA).
 
B. Analysis of  peripheral blood cells: The analysis of  
peripheral blood cells (e.g., total and differential count) 
was performed on a Beckman Coulter AcT 5diff  hema-
tology analyzer. The values are expressed in percentages 
and absolute numbers.
C. Flow cytometry analysis: The human leukocyte 
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differentiation antigens CD3, CD4 and CD8 (Beckman 
Coulter, Marseille, France)  Five microliters of  appropri-
ate monoclonal antibody was added to 50 µL of  a whole-
blood sample and incubated for 15 minutes at room tem-
perature. Thereafter, the erythrocytes were lysed with 125 
µL of  a lysing solution, OptiLyse C, for 10 minutes. The 
reaction was stopped by the addition of  250 µL phos-
phate-buffered saline.The samples were analyzed by flow 
cytometry using Cytomics FC 500 and CXP software 
(Beckman Coulter).The leukocyte subsets were defined 
by forward- and side-scatter pattern. The negative control 
value was determined by a fluorescence background and 
antibody-nonspecific staining.
 
D. Body mass index (BMI): Weight and height scale 
(Metrotype –England) was used to measure weight and 
height to calculate the body mass index (BMI). Body mass 
index was calculated by dividing the weight in kilograms 
by the square of  the height in meters (Kg/m2). Accord-
ing to the WHO classification, a BMI of  <18.5 kg/m2 is 
under weight, 18.5-24.9 kg/m2 is normal 25-29.9 kg/m2 is 
overweight. A BMI of  > 30 kg/m2 is classified as obese 
and this group is further divided into moderate obesity 
(30-34.9 kg/m2), severe obesity (35-39.9 kg/m2) and very 
severe obesity (≤40 kg /m2)31.   
 
Procedures
Following the previous evaluation , all patients were di-
vided randomly into the following groups:
1. The training group (Group A): These were submit-
ted to aerobic exercise training to complete a 12-week 
treadmill aerobic exercise (Enraf  Nonium, Model display 
panel Standard, NR 1475.801, Holland) which was con-
ducted according to recommendation of  aerobic exercise 
application approved by the American College of  Sports 
Medicine32. Training program included 5 minutes for 
warming –up in the form of  range motion and stretching 
exercises , 30 minutes of  aerobic exercise training with 
intensity equal 60-70% of  the individual maximum heart 
rate followed by cooling down for 10 minutes ( on tread-
mill with low speed and without inclination). Participants 
had 3 sessions /week for 3 months with close supervision 
of  physical therapist. Also, a dietician performed an inter-
view-based food survey for all participants of  group (A) 
for detection of  feeding habits, abnormal dietary behav-
ior and to prescribe the balanced low caloric diet33 that 
provided 1200 Kilocalories/day for 12 weeks. The same 
dietitian continuously monitored all participant caloric 
intakes through reviewing the detailed record of  food in-
take every 2 weeks by the dietitian34,35.    
 




The mean values of  the investigated parameters obtained 
before and after three months in both groups were com-
pared using paired "t" test. Independent "t" test was used 
for the comparison between the two groups (P<0.05).
 
Results
The demographic and clinical characteristics of  the sub-
jects are shown in Table 1. There were no significant dif-
ferences between both groups regarding age, height, al-
bumin, fasting blood glucose, hemoglobin, total bilirubin, 
systolic blood pressure, diastolic blood pressure, body 
weight, body mass index (BMI), waist circumference, fat 
mass, alanine aminotransferase (ALT) and HCV viral.
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Table 1: Comparison of clinical data between HCV patients in both groups. 
 
  Group (A) Group (B) Significance 
Age (year) 50.21 ± 4.82 51.13 ± 3.27 P>0.05 
BMI (kg/m2) 32.16 ± 2.25 31.71 ± 3.11 P>0.05 
Waist circumference (cm) 94.33 ± 3.61 93.84 ± 4.53 P>0.05 
Fat mass (kg) 25.10 ± 2.43 24.63 ± 2.31 P>0.05 
ALT (U/L) 66.45 ± 7.28 65.37 ± 6.19 P>0.05 
Albumin (gm/dl) 3.72 ± 0.92 3.46± 0.86 P>0.05 
FPG (mg/dL) 113.91 ± 10.75 110.81 ± 8.42 P>0.05 
Hb (gm/dl) 11.93 ± 1.64 12.16± 1.76 P>0.05 
Total Bilirubin (mg/dl) 1.41 ± 0.82 1.39 ± 0.75 P>0.05 
SBP (mm Hg) 125.42  ± 12.41 122.63 ± 10.33 P>0.05 
DBP (mm Hg) 84.70 ± 6.57 83.95 ± 7.48 P>0.05 
HCV viral load (IU/mL) 7.62 ± 3.81 × 106 7.31 ± 3.94 × 106 P>0.05 
             
                    BMI: Body Mass Index; Hb: Hemoglobin; FPG: Fasting Blood Glucose; ALT: Alanine aminotransferase; SBP: Systolic blood  
                    pressure;DBP: Diastolic blood pressure. 
The mean values of  BMI, white blood cells, total neu-
trophil count, monocytes, CD3, CD4 and CD8 were sig-
nificantly decreased in the training group as a result of  
weight loss program (table 2 and figure 2), however the 
results of  the control group were not significant (table 
3 and figure 3). Also, there were significant differences 
between both groups at the end of  the study (table 4 and 
figure 4).
Table 2: Mean value and significance of body mass index, white 
blood cells, total neutrophil, monocytes, CD3, CD4 and CD8 count 
of group (A) before and at the end of the study. 
 
  Mean +SD T-value Significance 
Pre Post 
BMI (kg/m2) 32.16 ± 2.25* 26.75 ± 2.12 8.24 P<0.05 
white blood cells 
count  (109/µL) 8.73 ± 2.54* 6.42 ±2.43 7.82 P<0.05 
total neutrophil count 
(109/µL) 5.61 ±1.81* 3.74 ±1.59 7.23 P<0.05 
Monocytes (109/µL) 0.71 ± 0.25* 0.48 ±0.16 5.41 P<0.05 
CD3 count (109/L) 1.85 ± 0.92* 1.46 ±0.71 6.52 P<0.05 
CD4 count (109/L) 1.34 ± 0.73* 0.92 ± 0.64 6.25 P<0.05 
CD8 count (109/L) 0.72 ± 0.23* 0.45 ± 0.12 5.17 P<0.05 
                     
                    BMI= Body Mass Index;    (*) indicates a significant difference between the two groups, P < 0.05. 
African Health Sciences Vol 18 Issue 2, June, 2018 420
 
Figure (1) : Subjects screening and recruitment  CONSORT diagram. 
Table 3: Mean value and significance of body mass index, 
white blood cells, total neutrophil, monocytes, CD3, CD4 and 
CD8 count of group (B) before and at the end of the study. 
 
  Mean +SD T-value Significance 
Pre Post 
BMI (kg/m2) 31.71 ± 3.11 31.85 ± 3.06 0.853 P>0.05 
white blood cells 
count  (109/µL) 8.69 ± 2.35 8.81 ± 2.42 
0.742 P>0.05 
total neutrophil count 
(109/µL) 5.47 ±1.66 5.53 ±1.68 
0.615 P>0.05 
Monocytes (109/µL) 0.74 ± 0.27 0.81 ± 0.29 0.378 P>0.05 
CD3 count (109/L) 1.62 ± 0.85 1.79 ± 0.87 0.432 P>0.05 
CD4 count (109/L) 1.27 ± 0.64 1.32 ± 0.66 0.419 P>0.05 
CD8 count (109/L) 0.68 ± 0.21 0.71 ± 0.22 0.326 P>0.05 
     
                   BMI= Body Mass Index;    (*) indicates a significant difference between the two groups, P < 0.05. 
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Table 4: Mean value and significance of body mass index, white blood cells, total neutrophil, 
monocytes, CD3, CD4 and CD8 count of group (A) and group (B) at the end of the study. 
 
  Mean +SD T-value Significance 
Group (A) Group (B) 
BMI (kg/m2) 26.75 ± 2.12* 31.85 ± 3.06 7.21     P<0.05 
white blood cells 
count  (109/µL) 6.42 ±2.43* 8.81 ± 2.42 6.39 
P<0.05 
total neutrophil count 
(109/µL) 3.74 ±1.59* 5.53 ±1.68 6.14 
P<0.05 
Monocytes (109/µL) 0.48 ±0.16* 0.81 ± 0.29 4.31 P<0.05 
CD3 count (109/L) 1.46 ±0.71* 1.79 ± 0.87 5.45 P<0.05 
CD4 count (109/L) 0.92 ± 0.64* 1.32 ± 0.66 5.28 P<0.05 
CD8 count (109/L) 0.45 ± 0.12* 0.71 ± 0.22 4.36 P<0.05 
                    
                   BMI= Body Mass Index;    (*) indicates a significant difference between the two groups, P < 0.05. 
Figure (2): Mean value of body mass index, white blood cells, total neutrophil,
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Figure (3): Mean value of body mass index, white blood cells, total neutrophil,


















Figure (4): Mean value of body mass index, white blood cells, total neutrophil, 
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Discussion
The best immune correlate of  HCV control is a strong 
and broad CD4+ T-cell response to HCV antigens, which 
is often associated with an equally robust and broad HCV 
specific CD8+ T-cell immune response36-38. It is believed 
that CD4+ T cells are necessary to ensure fully functional 
CD8+ T-cell responses, which then can clear the virus39. 
However, obesity is associated with the modulation of  
immune parameters40,41. To our knowledge, this is the first 
study of  immune function measures in relation to previ-
ous intentional weight loss in HCV patients. Our results 
indicate that there may be long-term effects of  intention-
al weight loss on immune function. These results are in 
line with several previous studies.
Shade and colleagues conducted a study on one hundred 
fourteen healthy, overweight, sedentary, post-menopausal 
women, who were recruited for an exercise intervention 
study and were currently weight stable who lost ≥ 10 
pounds had lower measured natural killer cell (NK) cyto-
toxicity than those who did not (24.7% ±12.1% vs 31.1% 
±14.7%, respectively). The frequency of  weight loss epi-
sodes was also associated with differences in the number 
and proportion of  NK cells. This study provides evidence 
that frequent intentional weight loss may have long-term 
effects on immune function42. However, Wasinski and col-
leagues conducted a study on mice who were submitted 
to chronic swimming training or a 30% caloric restriction 
after consuming a high-fat diet. The mice were subjected 
to swimming sessions 5 times per week for 6 weeks.Data 
demonstrated that exercise and caloric restriction modu-
late resident immune cells in adipose tissues. We observed 
a reduction in CD4+and CD8+ T lymphocytes in AT43. 
Also, Carpenter and colleagues evaluated the forced and 
voluntary exercise as weight-loss treatments in diet-in-
duced obese (DIO) mice and assessed the effects of  
weight loss on monocyte concentration and cell-surface 
expression of  Toll-like receptor. Results confirmed that 
short-term exercise and low-fat diet consumption over 
the 8 weeks caused significant weight loss and altered im-
mune profiles44.  While, Viardot and colleagues looked at 
13 obese people with Type 2 diabetes or pre-diabetes who 
were limited to a diet of  between 1000 and 1600 calories 
a day for 24 weeks. Gastric banding was performed at 12 
weeks to help restrict food intake further. Their results 
showed an 80% reduction of  pro-inflammatory T-help-
er cells, as well as reduced activation of  other circulating 
immune cells (T cells, monocytes and neutrophils) and 
decreased activation of  macrophages in fat45. Wing and 
colleagues examined subjects after weight loss, induced 
by 14-days fast, showed improvement in serum immuno-
globulin levels, bactericidal capacity of  blood monocytes 
and NK cell cytotoxic activity46. Moreover, Tanaka and 
colleagues reported that caloric restriction improves pa-
rameters of  immunity such as T cell counts and NK cell 
activity and the ability of  mononuclear cells to produce 
pro-inflammatory cytokines47. 
 
The possible mechanism of  immune system modulation 
by weight reduction could be explained by reduction of  
adipose tissues which is not only a storage organ, but pro-
duces close to 100 cytokines. These secreted adipokines 
are directly correlated to the increased adipose tissue mass 
and play an intricate role in various aspects of  the innate 
and adaptive immune response and participate in a wide 
variety of  physiological or physiopathological process-
es including food intake, insulin sensitivity and inflam-
mation48. Also, weight reduction reduces serum level of  
leptin. Leptin has pleiotropic effects on immune cell activ-
ity as evidenced from the presence of  leptin receptors on 
all immune cells of  both the arms of  innate and adaptive 
immunity49. Leptin promotes macrophage phagocytosis 
by activating phospholipase. Leptin increases secretion 
of  pro-inflammatory cytokines by macrophages. Leptin 
stimulates monocyte proliferation andupregulates the ex-
pression of  activation markers including CD38, CD69, 
CD25 and CD7150. Leptin is involved in the natural killer 
cell development, differentiation, proliferation, activation 
and cytotoxicity51. 
 
The current study has important strengths and limita-
tions. The major strength is the supervised nature of  the 
study. Supervising food intake and physical activity re-
moves the need to question compliance or to rely on food 
and activity questionnaires. Further, all exercise sessions 
were supervised and adherence to the diet and activities 
was essentially 100%. Moreover, the study was random-
ized; hence, we can extrapolate adherence to the general 
population. In the other hand, the major limitation is the 
small sample size in both groups which may limit the pos-
sibility of  generalization of  the findings in the present 
study. Finally, within the limit of  this study, weight reduc-
tion is recommended for  modulation of  immune sys-
tem parameters of  patients with HCV. Further researches 
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are needed to explore the impact of  weight reduction on 




The current study provides evidence that weight loss 
modulates immune system parameters of  patients with 
HCV.
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